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Past metabolic studies have focused on terminally differ-
entiated cells. These studies suggested that cells main-
tain bioenergetics through cell-autonomous uptake of
available extracellular nutrients, including glucose, lipids,
and amino acids, and feeding the catabolites of these
nutrients into the TCA cycle. However, recent studies
using different mammalian cell types have led to the dis-
covery that mammalian cells lack the cell autonomous
ability to take up nutrients. When cultured in the
absence of receptor ligands, mammalian cells lack the
ability to take up sufficient nutrients to sustain ATP
synthesis. In mammalian cells the uptake of extracellular
nutrients is directed by growth factor signaling.
Cellular dependence on ligand-directed nutrient uptake
establishes a mechanism by which all cells in multicellular
organisms might be rendered dependent on receptor
dependent signals for survival. In addition, the receptors
that direct nutrient uptake, when maximally stimulated,
can direct a cell to take up glucose in excess of its needs.
The major oncogenic determinants of glucose uptake are
receptor tyrosine kinases, PI3K, Akt, and TOR. Their acti-
vation results in the conversion of intermediate metabo-
lism to aerobic glycolysis (the Warburg Effect). The net
effect of this metabolism is a diversion of available amino
acids into protein synthesis and the establishment of an
alternative mitochondrial/cytoplasmic citric acid cycle that
converts glucose into lipids.
Although cell growth can be supported effectively by
aerobic glycolysis, the conversion from growth to prolifera-
tion relies on a cell’s ability to switch from glucose to gluta-
mine for the support of bioenergetics. The oncogene myc
has recently been implicated in this conversion. This con-
version allows glucose metabolites to be redirected into the
pentose phosphate shunt and into serine biosynthesis to
support nucleotide production and the maintenance of
cellular redox.
A role for intracellular metabolites in oncogenic signaling
and cellular differentiation has also been recently suggested
through studies of succinate dehydrogenase and fumarase
mutations in cancer. The discovery of cancer-associated
mutations in isocitrate dehydrogenase 1 and 2 that produce
a novel metabolite, 2-hydroxyglutarate, provides the most
compelling example of this principle to date. The implica-
tions of these recent findings to carcinogenesis and to the
development of novel therapeutics for cancer treatment
will be discussed.
Published: 28 May 2014
doi:10.1186/2049-3002-2-S1-O32
Cite this article as: Thompson: What cancer is teaching us about
cellular metabolism. Cancer & Metabolism 2014 2(Suppl 1):O32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Thompson Cancer & Metabolism 2014, 2(Suppl 1):O32
http://www.cancerandmetabolism.com/content/2/S1/O32 Cancer & 
Metabolism
© 2014 Thompson; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
